Literature DB >> 9377507

False-negative MR imaging of malignant breast tumors.

C Boetes1, S P Strijk, R Holland, J O Barentsz, R F Van Der Sluis, J H Ruijs.   

Abstract

In this study we analyze MR-negative malignant lesions of the breast. A total of 204 patients with palpable and/or mammographic lesions were studied. The MR technique consisted of the turbo FLASH and MP-RAGE subtraction techniques. All patients underwent surgical biopsy and/or mastectomy and all specimens were examined by the correlative radiologic-histologic mapping technique. A total of 208 lesions were evaluated; 145 turned out to be malignant and 63 proved to be benign. Six malignant lesions were misinterpreted as benign on MR imaging; thus, suspicious contrast enhancement was present in 96 % of the lesions detected by mammography, US, or clinical examination. Especially 4 of the 17 ductal carcinoma in situ (DCIS) lesions were misinterpreted (23.5 %). Despite optimal technique, 6 malignant lesions were not identified by MR imaging. The highest prevalence of these MR occult lesions was in the group of DCIS. Although MR imaging has an important role in the evaluation of breast lesions and, primarily, in ruling out malignancy, one should be aware of the fact that false-negative MR findings do occur.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9377507     DOI: 10.1007/s003300050281

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  27 in total

1.  Investigating the limit of detectability of a positron emission mammography device: a phantom study.

Authors:  Nicholas A Shkumat; Adam Springer; Christopher M Walker; Eric M Rohren; Wei T Yang; Beatriz E Adrada; Elsa Arribas; Selin Carkaci; Hubert H Chuang; Lumarie Santiago; Osama R Mawlawi
Journal:  Med Phys       Date:  2011-09       Impact factor: 4.071

2.  What is the sensitivity of mammography and dynamic MR imaging for DCIS if the whole-breast histopathology is used as a reference standard?

Authors:  F Sardanelli; L Bacigalupo; L Carbonaro; A Esseridou; G M Giuseppetti; P Panizza; V Lattanzio; A Del Maschio
Journal:  Radiol Med       Date:  2008-07-09       Impact factor: 3.469

3.  Does the degree of background enhancement in breast MRI affect the detection and staging of breast cancer?

Authors:  Takayoshi Uematsu; Masako Kasami; Junichiro Watanabe
Journal:  Eur Radiol       Date:  2011-06-18       Impact factor: 5.315

4.  In situ and minimally invasive breast cancer: morphologic and kinetic features on contrast-enhanced MR imaging.

Authors:  P Viehweg; D Lampe; J Buchmann; S H Heywang-Köbrunner
Journal:  MAGMA       Date:  2000-12       Impact factor: 2.310

5.  Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers.

Authors:  Julia Krammer; Katja Pinker-Domenig; Mark E Robson; Mithat Gönen; Blanca Bernard-Davila; Elizabeth A Morris; Debra A Mangino; Maxine S Jochelson
Journal:  Breast Cancer Res Treat       Date:  2017-03-25       Impact factor: 4.872

6.  Opinions of women with high inherited breast cancer risk about prophylactic mastectomy: an initial evaluation from a screening trial including magnetic resonance imaging and ductal lavage.

Authors:  Allison W Kurian; Anne-Renee Hartman; Meredith A Mills; James M Ford; Bruce L Daniel; Sylvia K Plevritis
Journal:  Health Expect       Date:  2005-09       Impact factor: 3.377

7.  Effect of vascular haemoglobin concentrations on ultrasound-guided diffuse optical tomography in differentiating benign from malignant breast lesions.

Authors:  Ning Lv; Ni He; Yaopan Wu; Chuanmiao Xie; Yue Wang; Yanan Kong; Weidong Wei; Peihong Wu
Journal:  Eur Radiol       Date:  2014-08-06       Impact factor: 5.315

8.  Comparing performance of the CADstream and the DynaCAD breast MRI CAD systems : CADstream vs. DynaCAD in breast MRI.

Authors:  Joann Pan; Basak E Dogan; Selin Carkaci; Lumarie Santiago; Elsa Arribas; Scott B Cantor; Wei Wei; R Jason Stafford; Gary J Whitman
Journal:  J Digit Imaging       Date:  2013-10       Impact factor: 4.056

9.  Multiparametric monitoring of tumor response to chemotherapy by noninvasive imaging.

Authors:  Zdravka Medarova; Leonid Rashkovetsky; Pamela Pantazopoulos; Anna Moore
Journal:  Cancer Res       Date:  2009-01-13       Impact factor: 12.701

10.  US-guided diffused optical tomography: a promising functional imaging technique in breast lesions.

Authors:  Shan-Shan You; Yu-Xin Jiang; Qing-Li Zhu; Ji-Bin Liu; Jing Zhang; Qing Dai; He Liu; Qiang Sun
Journal:  Eur Radiol       Date:  2009-08-26       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.